Patents-Review.com
ClassID:

116083 ⎘

C12Y207/1103 - CPC Classification

Classification description:

Transferases transferring phosphorus-containing groups (2.7); Protein-serine/threonine kinases (2.7.11) Receptor protein serine/threonine kinase (2.7.11.30)

Recent Application in this class:
#1
20260132406
2026-05-14

RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use

 #2
20250382386
2025-12-18

ANTI-ALK-1 ANTIBODY AND USE THEREOF

 #3
20250320517
2025-10-16

SOLANACEOUS PLANT RESISTANT TO VIRUS OF GENUS BEGOMOVIRUS CAUSING TOMATO YELLOW LEAF CURL SYMPTOMS, SOLANACEOUS PLANT CELL, AND METHOD FOR PRODUCING SOLANACEOUS PLANT

 #4
20250207139
2025-06-26

RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use

 #5
20250084388
2025-03-13

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

 #6
20240158468
2024-05-16

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

 #7
20240117354
2024-04-11

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES

 #8
20230295662
2023-09-21

GENE THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

 #9
20220396607
2022-12-15

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

 #10
20220177915
2022-06-09

Gene therapeutics for fibrodysplasia ossificans progressiva

 #11
20220119491
2022-04-21

ALK7:ActRIIB heteromultimers and uses thereof

 #12
20220098559
2022-03-31

ISOLATED GDF TRAP POLYPEPTIDE

 #13
20210363502
2021-11-25

Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers

 #14
20210207107
2021-07-08

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

 #15
20200246438
2020-08-06

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

 #16
20200208124
2020-07-02

Methods for treating anemia in a subject in need thereof

 #17
20200199548
2020-06-25

Methods for treating anemia in a subject in need thereof

 #18
20200199547
2020-06-25

Methods for treating anemia in a subject in need thereof

 #19
20200199546
2020-06-25

ISOLATED GDF TRAP POLYPEPTIDE

 #20
20200165583
2020-05-28

ISOLATED GDF TRAP POLYPEPTIDE

 #21
20200157512
2020-05-21

Methods and compositions for reducing serum lipids

 #22
20200109193
2020-04-09

Methods and compositions for treating ulcers

 #23
20190375820
2019-12-12

ALK7:actriib heteromultimers and uses thereof

 #24
20190352619
2019-11-21

ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS

 #25
20190314401
2019-10-17

ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING

 #26
20190225669
2019-07-25

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

 #27
20180305438
2018-10-25

BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH

 #28
20180194834
2018-07-12

Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB polypeptide

 #29
20180163187
2018-06-14

ALK4.ActRIIB heteromultimers

 #30
20180080012
2018-03-22

Method for producing an ActRIIB-Fc fusion polypeptide

 #31
20180042998
2018-02-15

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

 #32
20170327800
2017-11-16

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

 #33
20170319614
2017-11-09

Antisense-oligonucleotides as inhibitors of TGF-R signaling

 #34
20170204382
2017-07-20

Methods of identifying ActRIIB variants

 #35
20170152490
2017-06-01

USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER

 #36
20170137791
2017-05-18

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

 #37
20160319254
2016-11-03

ACTIVIN-ACTRIIA ANTAGONISTS FOR INHIBITING GERM CELL MATURATION

 #38
20160298093
2016-10-13

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

 #39
20160297867
2016-10-13

ALK7:ActRIIB heteromultimers and uses thereof

 #40
20160279207
2016-09-29

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

 #41
20160199458
2016-07-14

METHODS OF PROMOTING FAT LOSS COMPRISING ADMINISTERING AN ALK7 INHIBITOR

 #42
20160186148
2016-06-30

Method for decreasing the body fat content in a subject by administering an ActRIIB protein

 #43
20160138029
2016-05-19

Antisense-oligonucleotides as inhibitors of TGF-R signaling

 #44
20160108379
2016-04-21

ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS

 #45
20160039922
2016-02-11

Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide

 #46
20150299677
2015-10-22

USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER

 #47
20150266941
2015-09-24

BMP-ALK3 antagonists and uses for promoting bone growth

 #48
20130065299
2013-03-14

ACTRIIB-FC polynucleotides, polypeptides, and compositions

 #49
20120183540
2012-07-19

Methods of promoting fat loss comprising administering an ALK7 inhibitor

 #50
20120015877
2012-01-19

Isolated GDF trap polypeptide

 #51
20110218147
2011-09-08

Activin-actriia antagonists for inhibiting germ cell maturation

 #52
20100322925
2010-12-23

ALK7 AND MYOSTATIN INHIBITORS AND USES THEREOF

 #53
20100316644
2010-12-16

Isolated nucleic acid encoding a truncated ActRIIB fusion protein

 #54
20100267133
2010-10-21

Actriib-Fc polynucleotides, polypeptides, and compositions

 #55
20100266612
2010-10-21

BMP-ALK3 antagonists and uses for promoting bone growth

 #56
20100068215
2010-03-18

Method of increasing red blood cell levels or treating anemia in a patient

 #57
20090118188
2009-05-07

Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion

 #58
20090098114
2009-04-16

Methods of promoting growth of muscle tissue using ALK7

 #59
20090074768
2009-03-19

Activin-actriia antagonists and uses for treating or preventing breast cancer

 #60
20060068468
2006-03-30

ActRII receptor polypeptides, methods and compositions

 #61
20060030522
2006-02-09

ALK7 and myostatin inhibitors and uses thereof